These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
129 related items for PubMed ID: 6355878
1. Apoprotein A and apoprotein B in patients with chronic renal failure undergoing hemodialysis and in renal graft recipients. Rubiés-Prat J, Romero R, Chacón P, Masdeu S, Griño J, Caralps A. Nephron; 1983; 35(3):171-4. PubMed ID: 6355878 [Abstract] [Full Text] [Related]
2. [Changes in HDL-cholesterol, subfractions HDL2 and HDL3 and apo-A, apo-A1 and apo-B lipoproteins in patients with chronic renal failure subjected to maintenance hemodialysis]. Scarazatti E, Garavaglia G. Boll Soc Ital Biol Sper; 1985 Jan 30; 61(1):15-21. PubMed ID: 3977994 [Abstract] [Full Text] [Related]
3. De novo development of hypercholesterolemia and elevated high-density lipoprotein cholesterol: apoprotein A-I ratio in patients with chronic renal failure following kidney transplantation. Kobayashi N, Okubo M, Marumo F, Uchida H, Endo T, Nakamura H. Nephron; 1983 Jan 30; 35(4):237-40. PubMed ID: 6417553 [Abstract] [Full Text] [Related]
4. De novo development of hypercholesterolaemia and increased HDL-cholesterol: apoprotein A-I ratio in patients with chronic renal failure following kidney transplantation. Kobayashi N, Okubo M, Marumo F. Proc Eur Dial Transplant Assoc; 1983 Jan 30; 19():505-9. PubMed ID: 6410382 [Abstract] [Full Text] [Related]
5. Apoprotein A-I and high density lipoprotein subfractions in patients with chronic renal failure receiving hemodialysis. Joven J, Rubiés-Prat J, Espinel E, Chacón P, Olmos A, Masdeu S. Nephron; 1985 Jan 30; 40(4):451-4. PubMed ID: 3927179 [Abstract] [Full Text] [Related]
7. Increased lipoprotein-remnant formation in chronic renal failure. Nestel PJ, Fidge NH, Tan MH. N Engl J Med; 1982 Aug 05; 307(6):329-33. PubMed ID: 7088097 [Abstract] [Full Text] [Related]
8. Utility of non-high-density lipoprotein cholesterol in hemodialyzed patients. Schreier L, González AI, Elbert A, Berg G, Wikinski R. Metabolism; 2004 Aug 05; 53(8):1013-5. PubMed ID: 15281010 [Abstract] [Full Text] [Related]
9. High-density lipoprotein in chronic renal failure and after renal transplantation. Savdie E, Gibson JC, Stewart JH, Simons LA. Br Med J; 1979 Apr 07; 1(6168):928-30. PubMed ID: 219935 [Abstract] [Full Text] [Related]
10. Racial differences in plasma high-density lipoproteins in patients receiving hemodialysis. A possible mechanism for accelerated atherosclerosis in white men. Goldberg AP, Harter HR, Patsch W, Schechtman KB, Province M, Weerts C, Kuisk I, McCrate MM, Schonfeld G. N Engl J Med; 1983 May 26; 308(21):1245-52. PubMed ID: 6405269 [Abstract] [Full Text] [Related]
11. Lipoprotein abnormalities in hyperlipidemic and normolipidemic men on hemodialysis with chronic renal failure. Sentí M, Romero R, Pedro-Botet J, Pelegrí A, Nogués X, Rubiés-Prat J. Kidney Int; 1992 May 26; 41(5):1394-9. PubMed ID: 1614054 [Abstract] [Full Text] [Related]
12. High density and low density lipoproteins in chronic renal failure before and after renal transplantation. Gibson JC, Savdie E, Simons LA, Stewart JH, Mahony JF. Aust N Z J Med; 1979 Apr 26; 9(2):136-42. PubMed ID: 222252 [Abstract] [Full Text] [Related]
13. Abnormalities in the composition of serum high density lipoprotein in renal transplant recipients. Jung K, Neumann R, Scholz D, Nugel E. Clin Nephrol; 1982 Apr 26; 17(4):191-4. PubMed ID: 7042146 [Abstract] [Full Text] [Related]
14. Plasma concentrations of non-esterified fatty acids in chronic renal failure in the United Arab Emirates. Gillett MP, Obineche EN, Khan ST, Abdulle AM. Saudi Med J; 2004 Nov 26; 25(11):1611-6. PubMed ID: 15573187 [Abstract] [Full Text] [Related]
15. Favorable effects of L-carnitine treatment on hypertriglyceridemia in hemodialysis patients: decisive role of low levels of high-density lipoprotein-cholesterol. Vacha GM, Giorcelli G, Siliprandi N, Corsi M. Am J Clin Nutr; 1983 Oct 26; 38(4):532-40. PubMed ID: 6624695 [Abstract] [Full Text] [Related]
16. Plasma cholesterol metabolism in end-stage renal disease. Difference between treatment by hemodialysis or peritoneal dialysis. Dieplinger H, Schoenfeld PY, Fielding CJ. J Clin Invest; 1986 Apr 26; 77(4):1071-83. PubMed ID: 3082933 [Abstract] [Full Text] [Related]
17. Defective high-density lipoprotein composition in patients on chronic hemodialysis. A possible mechanism for accelerated atherosclerosis. Rapoport J, Aviram M, Chaimovitz C, Brook JG. N Engl J Med; 1978 Dec 14; 299(24):1326-9. PubMed ID: 213715 [Abstract] [Full Text] [Related]
18. Lipid and apolipoproteins (ApoAI, ApoB, Apo CIII, ApoE) disturbance in hemodialysis (HD) and renal transplant (Tx) patients. Janicki K, Solski J, Janicka L, Kimak E, Bednarek-Skublewska A, Stettner S, Molas G. Ann Univ Mariae Curie Sklodowska Med; 2004 Dec 14; 59(1):459-66. PubMed ID: 16146031 [Abstract] [Full Text] [Related]
19. Longitudinal survey of apolipoproteins and atherogenic risk in hemodialysis and continuous ambulatory peritoneal dialysis patients. Burrell D, Antignani A, Fein PA, Goldwasser P, Mittman N, Avram MM. ASAIO Trans; 1990 Dec 14; 36(3):M331-5. PubMed ID: 2123635 [Abstract] [Full Text] [Related]
20. [Evaluation of the cardiovascular risk associated with atherosclerosis: HDL-cholesterol or apoproteins? (author's transl)]. Haïat R, Bugugnani MJ. Nouv Presse Med; 1982 Apr 24; 11(19):1487-9. PubMed ID: 6804931 [Abstract] [Full Text] [Related] Page: [Next] [New Search]